Journal of Reproduction & Infertility

Journal of Reproduction & Infertility

The Concepts and Consequences of Early Ovarian Ageing: A Caveat to Women’s Health

Authors
Department of Obstetrics and Gynaecology, NEIGRIHMS, Shillong, India
Abstract
Apparent rise in the incidence of infertility in females and the trend shifting towards delayed child bearing brought up the concept of ovarian ageing. Women in their early thirties show poor ovarian reserve which is an entity named as early ovarian ageing. Early ovarian ageing is mostly genetically determined, but acquired modifiable factors like smoking, or ovarian surgery have some roles. Infertility and subfertility are the only clinical recognizable sequelae in the early ovarian ageing. The worrisome fact is that the outcome of assisted reproductive techniques is also not that much encouraging. Even if ovarian priming with DHEA has raised hope in the assisted reproductive techniques for these patients, but more randomized trials are needed to support this. Screening of these women with antimullerian hormone, antral follicle count and genetic analysis may be useful for recommendation at appropriate biological time regarding conception or fertility preservation.
Keywords

  1. Faddy MJ, Gosden RG, Gougeon A, Richardson SJ, Nelson JF. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod. 1992;7(10):1342-6.
  2. Treloar SA, Do KA, Martin NG. Genetic influences on the age at menopause. Lancet. 1998;352(9134): 1084-5.
  3. Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L, et al. ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;26(7):1616-24.
  4. Bancsi LF, Broekmans FJ, Eijkemans MJ, de Jong FH, Habbema JD, te Velde ER. Predictors of poor ovarian response in in vitro fertilization: a prospective study copaing basal markers of ovarian reserve. Fertil Steril. 2002;77(2):328-36.
  5. Broekmans FJ, Scheffer GJ, Bancsi LF, Dorland M, Blankenstein MA, te Velde ER. Ovarian reserve tests in infertility practice and normal fertile women. Maturitas. 1998;30(2):205-14.
  6. Cramer DW, Xu H, Harlow BL. Family history as a predictor of early menopause. Fertil Steril. 1995;64(4):740-5.
  7. de Bruin JP, Bovenhuis H, van Noord PA, Pearson PL, van Arendonk JA, te Velde ER, et al. The role of genetic factors in age at natural menopause. Hum Reprod. 2001;16(9):2014-8.
  8. Lass A, Ellenbogen A, Croucher C, Trew G, Margara R, Becattini C, et al. Effect of salpingectomy on ovarian response to superovulation in an in vitro fertilization-embryo transfer program. Fertil Steril. 1998;70(6):1035-8.
  9. Tulandi T, Sammour A, Valenti D, Child TJ, Seti L, Tan SL. Ovarian reserve after uterine artery embolization for leiomyomata. Fertil Steril. 2002;78(1): 197-8.
  10. Keay SD, Liversedge NH, Jenkins JM. Could ovarian infection impair ovarian rsponse to gonadotrophin stimulation? Br J Obstet Gynaecol. 1998;105(3):252-3.
  11. Sharara FI. "Poor responders" to gonadotropins and levels of antibodies to Chlamydia trachomatis? Fertil Steril. 1999;71(2):388-9.
  12. Barnhart K, DunsmoorSu R, Coutifaris C. Effect of endometriosis on in vitro fertiltion. Fertil Steril. 2002;77(6):1148-55.
  13. Augood C, Duckitt K, Templeton AA. Smoking and female infertility: a systematic review and meta-analysis. Hum Reprod. 1998;13(6):1532-9.
  14. Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol. 1986;67(4):604-6.
  15. Qin CR, Chen SL, Chen X, Xia R, Luo YQ. [Clinical features of women with idipathic premature ovarian failure]. Nan Fang Yi Ke Da Xue Xue Bao. 2011;31(5):886-9. Chinese.
  16. Sills ES, Brady AC, Omar AB, Walsh DJ, Salma U, Walsh AP. IVF for premature ovarian failure: first reported births using oocytes donated from a twin sister. Reprod Biol Endocrinol. 2010;8:31.
  17. te Velde ER, Scheffer GJ, Dorland M, Broekmans FJ, Fauser BC. Developmental and endocrine aspects of normal ovarian aging. Mol Cell Endocrinol. 1998;145(1-2):67-73.
  18. Lambalk CB, De Koning CH, Braat DD. The endocrinology of dizygotic twinning in the human. Mol Cell Endocrinol. 1998;145(1-2):97-102.
  19. Navot D, Bergh PA, Williams MA, Garrisi GJ, Guzman I, Sandler B, et al. Poor ocyte quality rather than implantation failure as a cause of agerelated decline in fmale fertility. Lancet. 1991;337(8754):1375-7.
  20. Liu L, Keefe DL. Ageing-associated aberration in meiosis of oocytes from senecence-accelerated mice. Hum Reprod. 2002;17(10):2678-85.
  21. Hunt PA. The control of mammalian female meiosis: factors that influence chromsome segregation. J Assist Reprod Genet. 1998;15(5):246-52.
  22. Check JH. Low and high responders--at what levels of serum estradiol do things start to get fuzzy? Fertil Steril. 1999;71(3):582-3; author reply 584-6.
  23. Check JH, Nazari P, Check ML, Choe JK, Liss JR. Prognosis following in vitro fetilization-embryo transfer (IVF-ET) in patients with elevated day 2 or 3 serum follicle stimulating hormone (FSH) is better in younger vs older patients. Clin Exp Obstet Gynecol. 2002;29(1):42-4.
  24. Hanoch J, Lavy Y, Holzer H, Hurwitz A, Simon A, Revel A, et al. Young low rsponders protected from untoward effects of reduced ovarian response. Fertil Steril. 1998;69(6):1001-4.
  25. Figueira Rde C, Braga DP, Nichi M, Madaschi C, Semião-Francisco L, Iaconelli A, et al. Poor ovarian response in patients younger than 35 years: is it also a qualitative decline in ovarian function? Hum Fertil. 2009;12(3):160-5.
  26. Soules MR, Sherman S, Parrott E, Rebar R, Santoro N, Utian W, et al. Executive summary: Stages of Reproductive Aging Workshop (STR AW). Fertil Steril. 2001;76(5):874-8.
  27. Treloar AE, Boynton RE, Behn BG, Brown BW. Variation of the human menstrual cycle through reproductive life. Int J Fertil. 1967;12(1 Pt 2):77-126.
  28. Matthews K, Sutton-Tyrrell K. What’s new about menopause and cardiovascular risk? Sex Reprod Menopause [Internet]. 2010 Aug [cited 2012 Apr 10]; 18(3):S8-S12. Available from: http://www. srm-ejournal.com/pdf% 2FMed0%2FMenMed08 10_Matthews.pdf
  29. Chu M, Rath K, Taylor H. Diminished ovarian reserve in normal cycling women is a predictor of unfavourable lipid levels and increased cardiovascular risk. Fertil Steril. 2001;76 (Suppl):S159–S 160.
  30. van Montfrans JM, van Hooff MH, Martens F, Lambalk CB. Basal FSH, estradiol and inhibin B concentrations in women with a previous Down's syndrome affected pregnancy. Hum Reprod. 2002;17(1):44-7.
  31. Chu MC, Rath KM, Huie J, Taylor HS. Elevated basal FSH in normal cycling women is associated with unfavourable lipid levels and increased cardiovascular risk. Hum Reprod. 2003;18(8):1570-3.
  32. Dorland M, van Kooij RJ, te Velde ER. General ageing and ovarian ageing. Maturitas. 1998;30(2): 113-8.
  33. Ossewaarde ME, Bots ML, Verbeek AL, Peeters PH, van der Graaf Y, Grobbee DE, et al. Age at menopause, causespecific mortality and total life expectancy. Epidemiology. 2005;16(4):556-62.
  34. Hefler LA, Grimm C, Bentz EK, Reinthaller A, Heinze G, Tempfer CB. A model for predicting age at menopause in white women. Fertil Steril. 2006; 85(2):451-4.
  35. Barad D, Brill H, Gleicher N. Update on the use of dehydroepiandrosterone supple-mentation among women with diminished ovarian function. J Assist Reprod Genet. 2007;24(12):629-34.
  36. de Bruin JP, Dorland M, Bruinse HW, Spliet W, Nikkels PG, Te Velde ER. Fetal growth retardation as a cause of impaired ovarian development. Early Hum Dev. 1998;51(1):39-46.
  37. Cresswell JL, Egger P, Fall CH, Osmond C, Fraser RB, Barker DJ. Is the age of menopause determined in-utero? Early Hum Dev. 1997;49(2):143-8.
  38. Tao T, Del Valle A. Human oocyte and ovarian tissue cryopreservation and its applcation. J Assist Reprod Genet. 2008;25(7):287-96.
  39. Poirot C, Schubert B. [Fertility preservation in prepubertal children]. Bull Cancer. 2011;98(5): 489-99. French.